TapewireFind a company

person · Reporting owner

Coen Steven P.

Disclosed activity across 1 company

Tapewire entity
19781
SEC CIK
0001977441

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Ginkgo Bioworks Holdings, Inc.DNA · Entity 5530See remarksOctober 05, 2026October 07, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Ginkgo Bioworks Holdings, Inc.

Report date October 05, 2026 · Filed October 07, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeDirect49,448 Reported balance After 2026-10-05 transaction · row 1
1 source row

Row 1 · 2026-10-05 · Sale · Disposed 2,403 · Balance 49,448

F1: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934

Filing footnotes · ownership attribution and instrument terms

F1: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
October 05, 2026 Filed Oct 7, 2026 21:00 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 SaleClass A Common Stock 2,403 $15.00 $36,045.00
Disclosure

SEC source: 0001628280-26-065349 · wk-form4_1791406827.xml · nonDerivative · entry 1

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,448

F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934

Read SEC document
August 24, 2026 Filed Aug 25, 2026 21:01 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 SaleClass A Common Stock 330 $6.98 $2,302.41
Disclosure

SEC source: 0001628280-26-058939 · wk-form4_1787691673.xml · nonDerivative · entry 3

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,851

F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.

Read SEC document
August 21, 2026 Filed Aug 25, 2026 21:01 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 156 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-058939 · wk-form4_1787691673.xml · derivative · entry 5

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,975

Underlying: Class A Common Stock · 156 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

Read SEC document
August 21, 2026 Filed Aug 25, 2026 21:01 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 587 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-058939 · wk-form4_1787691673.xml · derivative · entry 4

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,296

Underlying: Class A Common Stock · 587 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

Read SEC document
August 21, 2026 Filed Aug 25, 2026 21:01 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 156 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-058939 · wk-form4_1787691673.xml · nonDerivative · entry 2

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,181

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
August 21, 2026 Filed Aug 25, 2026 21:01 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 587 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-058939 · wk-form4_1787691673.xml · nonDerivative · entry 1

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,025

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
July 17, 2026 Filed Jul 20, 2026 21:00 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 SaleClass A Common Stock 752 $7.90 $5,943.06
Disclosure

SEC source: 0001628280-26-048832 · wk-form4_1784581219.xml · nonDerivative · entry 3

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,438

F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.

Read SEC document
July 16, 2026 Filed Jul 20, 2026 21:00 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 312 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-048832 · wk-form4_1784581219.xml · derivative · entry 5

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,131

Underlying: Class A Common Stock · 312 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

Read SEC document
July 16, 2026 Filed Jul 20, 2026 21:00 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 1,174 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-048832 · wk-form4_1784581219.xml · derivative · entry 4

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,883

Underlying: Class A Common Stock · 1,174 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

Read SEC document
July 16, 2026 Filed Jul 20, 2026 21:00 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 312 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-048832 · wk-form4_1784581219.xml · nonDerivative · entry 2

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,190

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
July 16, 2026 Filed Jul 20, 2026 21:00 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 1,174 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-048832 · wk-form4_1784581219.xml · nonDerivative · entry 1

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,878

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
May 22, 2026 Filed May 26, 2026 21:04 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 SaleClass A Common Stock 307 $8.33 $2,558.54
Disclosure

SEC source: 0001628280-26-038202 · wk-form4_1779829445.xml · nonDerivative · entry 3

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,704

F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.

Read SEC document
May 21, 2026 Filed May 26, 2026 21:04 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 156 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-038202 · wk-form4_1779829445.xml · derivative · entry 5

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,443

Underlying: Class A Common Stock · 156 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

Read SEC document
May 21, 2026 Filed May 26, 2026 21:04 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 587 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-038202 · wk-form4_1779829445.xml · derivative · entry 4

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,057

Underlying: Class A Common Stock · 587 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

Read SEC document
May 21, 2026 Filed May 26, 2026 21:04 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 156 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-038202 · wk-form4_1779829445.xml · nonDerivative · entry 2

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,011

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
May 21, 2026 Filed May 26, 2026 21:04 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 587 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-038202 · wk-form4_1779829445.xml · nonDerivative · entry 1

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,855

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
April 17, 2026 Filed Apr 20, 2026 21:02 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 SaleClass A Common Stock 324 $7.95 $2,576.45
Disclosure

SEC source: 0001628280-26-026038 · wk-form4_1776718959.xml · nonDerivative · entry 3

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,268

F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.

Read SEC document
April 16, 2026 Filed Apr 20, 2026 21:02 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 156 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-026038 · wk-form4_1776718959.xml · derivative · entry 5

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,599

Underlying: Class A Common Stock · 156 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

Read SEC document
April 16, 2026 Filed Apr 20, 2026 21:02 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 587 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-026038 · wk-form4_1776718959.xml · derivative · entry 4

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,644

Underlying: Class A Common Stock · 587 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

Read SEC document
April 16, 2026 Filed Apr 20, 2026 21:02 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 156 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-026038 · wk-form4_1776718959.xml · nonDerivative · entry 2

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,592

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
April 16, 2026 Filed Apr 20, 2026 21:02 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 587 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-026038 · wk-form4_1776718959.xml · nonDerivative · entry 1

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,436

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
April 13, 2026 Filed Apr 14, 2026 21:00 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 SaleClass A Common Stock 33,171 $6.41 $212,758.79
Disclosure

SEC source: 0001628280-26-025107 · wk-form4_1776200454.xml · nonDerivative · entry 3

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,849

F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of PSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.

Read SEC document
April 10, 2026 Filed Apr 14, 2026 21:00 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionPerformance-Based Restricted Stock Unit · Derivative 45,553 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-025107 · wk-form4_1776200454.xml · derivative · entry 5

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 45,553 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: On May 21, 2025, in connection with the Reporting Person's elevation to Chief Financial Officer, the Reporting Person was granted 67,991 PSUs based on a company-wide cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 10, 2026 in the form of Class A Common Stock reflects actual performance equal to 67% of the company-wide target, as certified by the Compensation Committee of the Board of Directors.

F4 · derivative.expiration_date: On May 21, 2025, in connection with the Reporting Person's elevation to Chief Financial Officer, the Reporting Person was granted 67,991 PSUs based on a company-wide cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 10, 2026 in the form of Class A Common Stock reflects actual performance equal to 67% of the company-wide target, as certified by the Compensation Committee of the Board of Directors.

Read SEC document
April 10, 2026 Filed Apr 14, 2026 21:00 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionPerformance-Based Restricted Stock Unit · Derivative 28,368 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-025107 · wk-form4_1776200454.xml · derivative · entry 4

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 28,368 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: On March 6, 2025, the Reporting Person was granted 45,755 based on a finance team cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 10, 2026 in the form of Class A Common Stock reflects actual performance equal to 62% of the finance team target, as certified by the Compensation Committee of the Board of Directors.

F3 · derivative.expiration_date: On March 6, 2025, the Reporting Person was granted 45,755 based on a finance team cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 10, 2026 in the form of Class A Common Stock reflects actual performance equal to 62% of the finance team target, as certified by the Compensation Committee of the Board of Directors.

Read SEC document
April 10, 2026 Filed Apr 14, 2026 21:00 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 45,553 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-025107 · wk-form4_1776200454.xml · nonDerivative · entry 2

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,020

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
April 10, 2026 Filed Apr 14, 2026 21:00 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 28,368 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-025107 · wk-form4_1776200454.xml · nonDerivative · entry 1

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,467

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
March 16, 2026 Filed Mar 18, 2026 21:00 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 SaleClass A Common Stock 708 $6.74 $4,768.38
Disclosure

SEC source: 0001628280-26-019475 · wk-form4_1773867620.xml · nonDerivative · entry 3

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,099

F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.

Read SEC document
March 13, 2026 Filed Mar 18, 2026 21:00 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 312 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-019475 · wk-form4_1773867620.xml · derivative · entry 5

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,755

Underlying: Class A Common Stock · 312 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

Read SEC document
March 13, 2026 Filed Mar 18, 2026 21:00 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 1,174 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-019475 · wk-form4_1773867620.xml · derivative · entry 4

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,231

Underlying: Class A Common Stock · 1,174 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

Read SEC document
March 13, 2026 Filed Mar 18, 2026 21:00 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 312 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-019475 · wk-form4_1773867620.xml · nonDerivative · entry 2

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,807

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
March 13, 2026 Filed Mar 18, 2026 21:00 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 1,174 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-019475 · wk-form4_1773867620.xml · nonDerivative · entry 1

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,495

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
January 20, 2026 Filed Jan 22, 2026 21:12 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 SaleClass A Common Stock 972 $8.92 $8,667.32
Disclosure

SEC source: 0001628280-26-003084 · wk-form4_1769116333.xml · nonDerivative · entry 4

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,321

F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.

Read SEC document
January 16, 2026 Filed Jan 22, 2026 21:12 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 1,062 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-003084 · wk-form4_1769116333.xml · derivative · entry 7

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 1,062 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F5 · derivative.exercise_date: The RSUs vest as follows: 25% vested on April 16, 2025; 25% vested on July 16, 2025; 25% vested on October 16, 2025; and 25% vested on January 16, 2026.

F5 · derivative.expiration_date: The RSUs vest as follows: 25% vested on April 16, 2025; 25% vested on July 16, 2025; 25% vested on October 16, 2025; and 25% vested on January 16, 2026.

Read SEC document
January 16, 2026 Filed Jan 22, 2026 21:12 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 156 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-003084 · wk-form4_1769116333.xml · derivative · entry 6

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,067

Underlying: Class A Common Stock · 156 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

Read SEC document
January 16, 2026 Filed Jan 22, 2026 21:12 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 587 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-003084 · wk-form4_1769116333.xml · derivative · entry 5

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,405

Underlying: Class A Common Stock · 587 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

Read SEC document
January 16, 2026 Filed Jan 22, 2026 21:12 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 1,062 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-003084 · wk-form4_1769116333.xml · nonDerivative · entry 3

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,293

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
January 16, 2026 Filed Jan 22, 2026 21:12 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 156 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-003084 · wk-form4_1769116333.xml · nonDerivative · entry 2

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,231

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
January 16, 2026 Filed Jan 22, 2026 21:12 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 587 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-003084 · wk-form4_1769116333.xml · nonDerivative · entry 1

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,075

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
December 15, 2025 Filed Dec 16, 2025 22:11 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 SaleClass A Common Stock 736 $8.89 $6,540.10
Disclosure

SEC source: 0001628280-25-057441 · wk-form4_1765923061.xml · nonDerivative · entry 3

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,488

F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.

Read SEC document
December 12, 2025 Filed Dec 16, 2025 22:11 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 312 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-057441 · wk-form4_1765923061.xml · derivative · entry 5

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,223

Underlying: Class A Common Stock · 312 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

Read SEC document
December 12, 2025 Filed Dec 16, 2025 22:11 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 1,174 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-057441 · wk-form4_1765923061.xml · derivative · entry 4

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,992

Underlying: Class A Common Stock · 1,174 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

Read SEC document
December 12, 2025 Filed Dec 16, 2025 22:11 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 312 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-057441 · wk-form4_1765923061.xml · nonDerivative · entry 2

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,224

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
December 12, 2025 Filed Dec 16, 2025 22:11 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 1,174 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-057441 · wk-form4_1765923061.xml · nonDerivative · entry 1

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,912

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
October 17, 2025 Filed Oct 21, 2025 20:56 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 SaleClass A Common Stock 1,312 $13.65 $17,907.49
Disclosure

SEC source: 0001977441-25-000010 · wk-form4_1761080182.xml · nonDerivative · entry 4

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,738

F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.

Read SEC document
October 16, 2025 Filed Oct 21, 2025 20:56 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 1,061 Not disclosed Not disclosed
Disclosure

SEC source: 0001977441-25-000010 · wk-form4_1761080182.xml · derivative · entry 7

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,062

Underlying: Class A Common Stock · 1,061 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F5 · derivative.exercise_date: The RSUs vest as follows: 25% vested on April 16, 2025; 25% vested on July 16, 2025; 25% vested on October 16, 2025; and 25% will vest on January 16, 2026.

F5 · derivative.expiration_date: The RSUs vest as follows: 25% vested on April 16, 2025; 25% vested on July 16, 2025; 25% vested on October 16, 2025; and 25% will vest on January 16, 2026.

Read SEC document
October 16, 2025 Filed Oct 21, 2025 20:56 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 312 Not disclosed Not disclosed
Disclosure

SEC source: 0001977441-25-000010 · wk-form4_1761080182.xml · derivative · entry 6

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,535

Underlying: Class A Common Stock · 312 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

Read SEC document
October 16, 2025 Filed Oct 21, 2025 20:56 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 1,174 Not disclosed Not disclosed
Disclosure

SEC source: 0001977441-25-000010 · wk-form4_1761080182.xml · derivative · entry 5

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,166

Underlying: Class A Common Stock · 1,174 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

Read SEC document
October 16, 2025 Filed Oct 21, 2025 20:56 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 1,061 Not disclosed Not disclosed
Disclosure

SEC source: 0001977441-25-000010 · wk-form4_1761080182.xml · nonDerivative · entry 3

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,050

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
October 16, 2025 Filed Oct 21, 2025 20:56 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 312 Not disclosed Not disclosed
Disclosure

SEC source: 0001977441-25-000010 · wk-form4_1761080182.xml · nonDerivative · entry 2

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,989

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
October 16, 2025 Filed Oct 21, 2025 20:56 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 1,174 Not disclosed Not disclosed
Disclosure

SEC source: 0001977441-25-000010 · wk-form4_1761080182.xml · nonDerivative · entry 1

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,677

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.